Differential flap dynamics in wild-type and a drug resistant variant of HIV-1 protease revealed by molecular dynamics and NMR relaxation

Journal of Chemical Theory and Computation

Volumn 8, Issue 10, 2012, Pages 3452-3462

  Cai, Yufeng ^a   Kurt Yilmaz, Nese ^a   Myint, Wazo ^b   Ishima, Rieko ^b   Schiffer, Celia A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867374992     PISSN: 15499618     EISSN: 15499626     Source Type: Journal    
DOI: 10.1021/ct300076y     Document Type: Article

References (53)

1. Flexner, C. HIV drug development: the next 25 years Nat. Rev. Drug Discovery 2007, 6 (12) 959-966
2. Heaslet, H.; Rosenfeld, R.; Giffin, M.; Lin, Y. C.; Tam, K.; Torbett, B. E.; Elder, J. H.; McRee, D. E.; Stout, C. D. Conformational flexibility in the flap domains of ligand-free HIV protease Acta Crystallogr., Sect. D 2007, 63 (Pt 8) 866-875
3. Wlodawer, A.; Miller, M.; Jaskolski, M.; Sathyanarayana, B. K.; Baldwin, E.; Weber, I. T.; Selk, L. M.; Clawson, L.; Schneider, J.; Kent, S. B. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease Science 1989, 245 (4918) 616-621
4. Spinelli, S.; Liu, Q. Z.; Alzari, P. M.; Hirel, P. H.; Poljak, R. J. The three-dimensional structure of the aspartyl protease from the HIV-1 isolate BRU Biochimie 1991, 73 (11) 1391-1396
5. Wlodawer, A.; Erickson, J. W. Structure-based inhibitors of HIV-1 protease Annu. Rev. Biochem. 1993, 62, 543-585
6. Lapatto, R.; Blundell, T.; Hemmings, A.; Overington, J.; Wilderspin, A.; Wood, S.; Merson, J. R.; Whittle, P. J.; Danley, D. E.; Geoghegan, K. F. X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes Nature 1989, 342 (6247) 299-302
7. Louis, J. M.; Ishima, R.; Nesheiwat, I.; Pannell, L. K.; Lynch, S. M.; Torchia, D. A.; Gronenborn, A. M. Revisiting monomeric HIV-1 protease. Characterization and redesign for improved properties J. Biol. Chem. 2003, 278 (8) 6085-6092
8. Galiano, L.; Ding, F.; Veloro, A. M.; Blackburn, M. E.; Simmerling, C.; Fanucci, G. E. Drug pressure selected mutations in HIV-1 protease alter flap conformations J. Am. Chem. Soc. 2009, 131 (2) 430-431
9. Furfine, E. S.; Dsouza, E.; Ingold, K. J.; Leban, J. J.; Spector, T.; Porter, D. J. T. 2-Step Binding Mechanism for Hiv Protease Inhibitors Biochemistry 1992, 31 (34) 7886-7891
10. Rodriguez, E. J.; Debouck, C.; Deckman, I. C.; Abusoud, H.; Raushel, F. M.; Meek, T. D. Inhibitor Binding to the Phe53trp Mutant of Hiv-1 Protease Promotes Conformational-Changes Detectable by Spectrofluorometry Biochemistry 1993, 32 (14) 3557-3563
11. Ishima, R.; Freedberg, D. I.; Wang, Y. X.; Louis, J. M.; Torchia, D. A. Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function Structure 1999, 7 (9) 1047-1055
12. Ishima, R.; Louis, J. M. A diverse view of protein dynamics from NMR studies of HIV-1 protease flaps Proteins 2008, 70 (4) 1408-1415
13. Freedberg, D. I.; Ishima, R.; Jacob, J.; Wang, Y. X.; Kustanovich, I.; Louis, J. M.; Torchia, D. A. Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations Protein Sci. 2002, 11 (2) 221-232
14. Galiano, L.; Bonora, M.; Fanucci, G. E. Interflap distances in HIV-1 protease determined by pulsed EPR measurements J. Am. Chem. Soc. 2007, 129 (36) 11004-11005
15. Galiano, L.; Blackburn, M. E.; Veloro, A. M.; Bonora, M.; Fanucci, G. E. Solute effects on spin labels at an aqueous-exposed site in the flap region of HIV-1 protease J. Phys. Chem. B 2009, 113 (6) 1673-1680
16. Cai, Y.; Schiffer, C. A. Decomposing the energetic impact of drug resistant mutations in HIV-1 protease on binding DRV J. Chem. Theory Comput. 2010, 6 (4) 1358-1368
17. Hornak, V.; Okur, A.; Rizzo, R. C.; Simmerling, C. HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state J. Am. Chem. Soc. 2006, 128 (9) 2812-2813
18. Scott, W. R.; Schiffer, C. A. Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance Structure 2000, 8 (12) 1259-1265
19. Perryman, A. L.; Lin, J. H.; McCammon, J. A. HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs Protein Sci. 2004, 13 (4) 1108-1123
20. Hornak, V.; Okur, A.; Rizzo, R. C.; Simmerling, C. HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (4) 915-920
21. Hornak, V.; Simmerling, C. Targeting structural flexibility in HIV-1 protease inhibitor binding Drug Discovery Today 2007, 12 (3-4) 132-138
22. Ozen, A.; Haliloglu, T.; Schiffer, C. A. Dynamics of Preferential Substrate Recognition in HIV-1 Protease: Redefining the Substrate Envelope J. Mol. Biol. 2011, 410 (4) 726-744
23. Mittal, S.; Cai, Y.; Nalam, M. N.; Bolon, D. N.; Schiffer, C. A. Hydrophobic Core Flexibility Modulates Enzyme Activity in HIV-1 Protease J. Am. Chem. Soc. 2012, 134 (9) 4163-4168
24. Ali, A.; Bandaranayake, R. M.; Cai, Y.; King, N. M.; Kolli, M.; Mittal, S.; Murzycki, J. F.; Nalam, M. N.; Nalivaika, E. A.; Ozen, A.; Prabu-Jeyabalan, M. M.; Thayer, K.; Schiffer, C. A. Molecular Basis for Drug Resistance in HIV-1 Protease Viruses 2010, 2 (11) 2509-2535
25. Kurt, N.; Scott, W. R.; Schiffer, C. A.; Haliloglu, T. Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations Proteins 2003, 51 (3) 409-422
26. King, N. M.; Prabu-Jeyabalan, M.; Nalivaika, E. A.; Wigerinck, P.; de Bethune, M. P.; Schiffer, C. A. Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor J. Virol. 2004, 78 (21) 12012-12021
27. Prabu-Jeyabalan, M.; Nalivaika, E. A.; King, N. M.; Schiffer, C. A. Viability of a drug-resistant HIV-1 protease variant: structural insights for better anti-viral therapy J. Virol. 2003, 77 (2) 1306-1315
28. King, N. M.; Prabu-Jeyabalan, M.; Nalivaika, E. A.; Schiffer, C. A. Combating susceptibility to drug resistance: Lessons from HIV-1 protease Chem. Biol. 2004, 11 (10) 1333-1338
29. Prabu-Jeyabalan, M.; Nalivaika, E.; Schiffer, C. A. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease J. Mol. Biol. 2000, 301 (5) 1207-1220
30. Foulkes, J. E.; Prabu-Jeyabalan, M.; Cooper, D.; Henderson, G. J.; Harris, J.; Swanstrom, R.; Schiffer, C. A. Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity J. Virol. 2006, 80 (14) 6906-6916
31. Shafer, R. W.; Stevenson, D.; Chan, B. Human immunodeficiency virus reverse transcriptase and protease sequence database Nucleic Acids Res. 1999, 27 (1) 348-352
32. King, N. M.; Prabu-Jeyabalan, M.; Bandaranayake, R. M.; Nalam, M. N.; Ozen, A.; Haliloglu, T.; Schiffer, C. Extreme Entropy-Enthalpy Compensation in a Drug Resistant Variant of HIV-1 Protease. In preparation, 2012.
33. Cai, Y.; Schiffer, C. Decomposing the energetic impact of drug-resistant mutations: the example of HIV-1 protease-DRV binding Methods Mol. Biol. 2012, 819, 551-560
34. Stocker, U.; van Gunsteren, W. F. Molecular dynamics simulation of hen egg white lysozyme: A test of the GROMOS96 force field against nuclear magnetic resonance data Proteins 2000, 40 (1) 145-153
35. Trzesniak, D.; Glattli, A.; Jaun, B.; van Gunsteren, W. F. Interpreting NMR data for beta-peptides using molecular dynamics simulations J. Am. Chem. Soc. 2005, 127 (41) 14320-14329
36. van Gunsteren, W. F.; Dolenc, J.; Mark, A. E. Molecular simulation as an aid to experimentalists Curr. Opin. Struct. Biol. 2008, 18 (2) 149-153
37. Daura, X.; Gademann, K.; Schafer, H.; Jaun, B.; Seebach, D.; van Gunsteren, W. F. The beta-peptide hairpin in solution: Conformational study of a beta-hexapeptide in methanol by NMR spectroscopy and MD simulation J. Am. Chem. Soc. 2001, 123 (10) 2393-2404
38. Case, D. A.; Cheatham, T. E., 3rd; Darden, T.; Gohlke, H.; Luo, R.; Merz, K. M., Jr.; Onufriev, A.; Simmerling, C.; Wang, B.; Woods, R. J. The Amber biomolecular simulation programs J. Comput. Chem. 2005, 26 (16) 1668-1688
39. Duan, Y.; Wu, C.; Chowdhury, S.; Lee, M. C.; Xiong, G.; Zhang, W.; Yang, R.; Cieplak, P.; Luo, R.; Lee, T.; Caldwell, J.; Wang, J.; Kollman, P. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations J. Comput. Chem. 2003, 24 (16) 1999-2012
40. Ryckaert, J.-P.; Ciccotti, G.; Berendsen, H. J. C. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 1977, 23, 327-341
41. Humphrey, W.; Dalke, A.; Schulten, K. VMD-Visual Molecular Dynamics J. Mol. Graphics 1996, 14 (1) 33-38
42. Smith, L. J.; Mark, A. E.; Dobson, C. M.; Vangunsteren, W. F. Comparison of Md Simulations and Nmr Experiments for Hen Lysozyme-Analysis of Local Fluctuations, Cooperative Motions, and Global Changes Biochemistry 1995, 34 (34) 10918-10931
43. Chandrasekhar, I.; Clore, G. M.; Szabo, A.; Gronenborn, A. M.; Brooks, B. R. A 500-Ps Molecular-Dynamics Simulation Study of Interleukin-1-Beta in Water-Correlation with Nuclear-Magnetic-Resonance Spectroscopy and Crystallography J. Mol. Biol. 1992, 226 (1) 239-250
44. Louis, J. M.; Clore, G. M.; Gronenborn, A. M. Autoprocessing of HIV-1 protease is tightly coupled to protein folding Nat. Struct. Biol. 1999, 6 (9) 868-875
45. Marley, J.; Lu, M.; Bracken, C. A method for efficient isotopic labeling of recombinant proteins J. Biomol. NMR 2001, 20 (1) 71-75
46. Ishima, R.; Torciha, D. A.; Louis, J. M. Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor J. Biol. Chem. 2007, 282 (23) 17190-17199
47. Ishima, R. Recent Developments in (15)N NMR Relaxation Studies that Probe Protein Backbone Dynamics Top. Curr. Chem. 2012, 326, 99-122
48. Farrow, N. A.; Zhang, O.; Forman-Kay, J. D.; Kay, L. E. Characterization of the backbone dynamics of folded and denatured states of an SH3 domain Biochemistry 1997, 36 (9) 2390-2402
49. Mandel, A. M.; Akke, M.; Palmer, A. G. Backbone Dynamics of Escherichia-Coli Ribonuclease Hi-Correlations with Structure and Function in an Active Enzyme J. Mol. Biol. 1995, 246 (1) 144-163
50. Lipari, G.; Szabo, A. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity J. Am. Chem. Soc. 1982, 104 (17) 4546-4559
51. Lipari, G.; Szabo, A. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results J. Am. Chem. Soc. 1982, 104 (17) 4559-4570
52. Clore, G. M.; Driscoll, P. C.; Wingfield, P. T.; Gronenborn, A. M. Analysis of the backbone dynamics of interleukin-1 beta using two-dimensional inverse detected heteronuclear 15N-1H NMR spectroscopy Biochemistry 1990, 29 (32) 7387-7401
53. Barchi, J. J., Jr.; Grasberger, B.; Gronenborn, A. M.; Clore, G. M. Investigation of the backbone dynamics of the IgG-binding domain of streptococcal protein G by heteronuclear two-dimensional 1H-15N nuclear magnetic resonance spectroscopy Protein Sci. 1994, 3 (1) 15-21